Success Stories: Holder of an NIW Approval from China Gets Green Card Along with EB-1B Petition Approval with the Help of Premium Processing Service Upgrade


Client’s Testimonial:

“I am giving WeGreened (WG) team a 5-star review for my petition’s approval without any RFE. WG team’s remote communication system is very efficient. They guarantee to draft time for the recommendation letters and petition letters. They also perform several rounds of quality checks and they can even catch very minor discrepancies before filing. This team deserves your trust in your immigration journey.”

On June 29th, 2021, we received another EB-1B (Outstanding Professors and Researchers) approval for a Research Scientist II in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Research Scientist II

Country of Origin: China

State of Residence at the Time of Filing: Tennessee

Approval Notice Date: June 29th, 2021

Processing Time: 7 days (Premium Processing Requested)

Case Summary:

When a research scientist II from China hired us to help him in documenting his I-140 NIW (National Interest Waiver) petition back in 2020, we made sure of his credentials and reviewed his proposed research background. We were certain that our unprecedented knowledge in building employment-based visa petitions will gain him the national interest waiver. We proved it right as his NIW petition achieved approval in less than 7 months after we filed his case.

Our satisfied client decided to retain our law firm for filing another petition under the I-140 EB1B (Outstanding Professors and Researchers) visa category since many petitioners get more than one petition filed to increase their chances to move faster to receiving the green card success. Thus, we began accumulating further evidence required for his EB-1B case.

Even though NIW and EB1B are two unique petitions, a few attributes remain the same; the client’s research brief and its impacting factors to the interests of the United States, the publishing record, and citation count. Also, the client’s active participation in the peer review activity. Thus, we outlined the most important aspects of our client’s EB1B case i.e., his research focus on developing new pharmaceutical drugs to prevent and treat life-threatening diseases. We deduced how his research improves disease diagnostics and drug development, as well as how to develop novel drug delivery systems and nano-medicine innovations, confirming that his research is of the utmost importance to major health-related concerns in the United States.

The distinctive point that we highlighted in his EB1B case was his major funding sources; affirmatively his work received funding support from the National Institutes of Health and the United States Department of Defense, therefore, this demonstrates that his work has clearly been recognized as valuable to the national security of the United States.

Also, our aim was to signify his outstanding academic and professional skills set, hence we further included that our client held a Ph.D. in pharmaceutical sciences and published 13 peer-reviewed journal articles in high impact and internationally circulated journals in the field, which altogether accumulated 138 citations from many researchers hailing from several prestigious and widespread institutes in Korea, Denmark, Netherlands, Turkey, Japan, and South Africa, among others. This apparently authenticates the international influence of our client’s work, as well as global implementation of it in the field. Not only did he accomplish his elite level in the field by publishing but also conducted peer reviews, proving his active and actual participation as a judge of the work of other experts in the field. We noted that he had already conducted 80 peer reviews at the time of filing for the petitions.

“[Client] has considerably added value to the existing literature on pharmaceutical sciences through his substantial publication history. He has authored a dozen articles in top-tier scientific journals. These journals only accept exceptional submissions that cover topics on the cutting-edge of research in pharmaceutical sciences. The inclusion of his papers in these periodicals, therefore, highlights the relevance of his work and distinguishes it as being of superior quality.”

The aforementioned excerpt has been contributed by one of his five well-reputed recommenders, concluding that our client has established himself as an instrumental figure within the field of pharmaceutical sciences, and his work has had a resounding influence on the medical community at large. Accordingly, his current research in the United States must continue unimpeded.

We are glad that our client obtained both the petition approvals in the span of 28 days with our team’s efficient efforts in his cases. Our client upgraded his EB-1B case to premium processing, therefore, the case got approved just 7 days after we filed the petition. However, the best part is he got the I-485 approvals even before his EB1B petition approval. We would like to thank him for letting us help him in achieving his green card success. We wish him well in his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.